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Abstract
Monocyte phenotype and output changes with age, but why this occurs and how it impacts
anti-bacterial immunity are not clear. We found that, in both humans and mice, circulating
monocyte phenotype and function was altered with age due to increasing levels of TNF in
the circulation that occur as part of the aging process. Ly6C+ monocytes from old (18–22
mo) mice and CD14+CD16+ intermediate/inflammatory monocytes from older adults also
contributed to this “age-associated inflammation” as they produced more of the inflamma-
tory cytokines IL6 and TNF in the steady state and when stimulated with bacterial products.
Using an aged mouse model of pneumococcal colonization we found that chronic exposure
to TNF with age altered the maturity of circulating monocytes, as measured by F4/80
expression, and this decrease in monocyte maturation was directly linked to susceptibility to
infection. Ly6C+ monocytes from old mice had higher levels of CCR2 expression, which pro-
moted premature egress from the bone marrow when challenged with Streptococcus pneu-
moniae. Although Ly6C+ monocyte recruitment and TNF levels in the blood and
nasopharnyx were higher in old mice during S. pneumoniae colonization, bacterial clear-
ance was impaired. Counterintuitively, elevated TNF and excessive monocyte recruitment
in old mice contributed to impaired anti-pneumococcal immunity since bacterial clearance
was improved upon pharmacological reduction of TNF or Ly6C+ monocytes, which were the
major producers of TNF. Thus, with age TNF impairs inflammatory monocyte development,
function and promotes premature egress, which contribute to systemic inflammation and is
ultimately detrimental to anti-pneumococcal immunity.
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Author Summary
As we age, levels of inflammatory cytokines in the blood and tissues increase. Although
this appears to be an inevitable part of aging, it ultimately contributes to declining health.
Epidemiological studies indicate that older adults with higher than age-average levels of
inflammatory cytokines are at increased risk of acquiring, becoming hospitalized with and
dying of Streptococcus pneumoniae pneumonia but how age-associated inflammation
increased susceptibility to was not entirely clear. We demonstrate that the increase in the
inflammatory cytokine TNF that occurs with age cause monocytes to leave the bone mar-
row prematurely and these immature monocytes produce more inflammatory cytokines
when stimulated with bacterial products, thus further increasing levels of inflammatory
cytokines in the blood. Furthermore, although old mice have higher levels of these inflam-
matory monocytes arriving at the site of S. pneumoniae, they are not able to clear the bac-
teria. By pharmacologically or genetically removing the inflammatory cytokine TNF or
reducing the number of inflammatory monocytes we were able to restore antibacterial
immunity in aged mice. Thus we demonstrate that monocytes are both influenced by and
contributors to age-associated inflammation and that chronic exposure to age-associated
inflammation increases susceptibility to S. pneumoniae due to altering monocyte maturity
and function.
Introduction
Monocyte phenotype and function change with age but whether these changes contribute to
susceptibility to infectious disease is unclear. In mice, monocytes can be subdivided based on
their expression of the Ly6C antigen into Ly6Chigh (Ly6Chigh, CCR2high, CX3CR1low) and
Ly6Clow (Ly6Clow, CCR2low, CX3CR1high) monocytes [1,2]. In humans, the functional equiva-
lents are CD14++CD16-/+ and CD14+CD16++ monocytes, respectively [1,3]. Ly6Chigh mono-
cyte output from the bone marrow to the blood increases in a CCR2-dependent manner early
during infection [4,5], and they become the dominant monocyte subtype in the blood, prefer-
entially homing to sites of inflammation[6]. Ly6Chigh monocytes produce high levels of inflam-
matory cytokines[4,5,7]; thus, they are often called “inflammatory monocytes”.
In the elderly, numbers of circulating CD14++CD16+ and CD14++CD16- monocytes, are sig-
nificantly higher[8]. CD14++CD16+ monocytes derived from elderly individuals are more
senescent (i.e. have shorter telomeres) than other monocyte subsets and produce more pro-
inflammatory cytokines (IL6, TNF, IL1β, IL12p70) and have higher levels of some chemokine
receptors (e.g. CCR2, CCR5, CCR7, CX3CR1) [9,10]. Due to their ability to produce large
amounts of pro-inflammatory cytokines, Ly6Chigh monocytes contribute to the pathology of
several models of chronic inflammation [11,12,13,14,15,16,17]. During chronic inflammatory
conditions, the number of circulating Ly6Chigh monocytes increase progressively[18] and their
ablation is an effective strategy for decreasing pathology [16,17,19,20]. Whether Ly6Chigh
monocytes contribute to chronic age-associated inflammation and increased susceptibility to
infection is not known and is the focus of this study.
Aging is accompanied by an increase in the levels of pro-inflammatory cytokines such as
tumour necrosis factor (TNF) and interleukins 1β (IL1β) and 6 (IL6) in the serum and tissues,
a phenomenon that has been termed “inflamm-aging”[reviewed in[21,22]]. This age-associ-
ated, systemic state of chronic, low-grade inflammation (defined as “para-inflammation” by
Medzhitov[23])is well-documented although its cellular source has yet to be definitively identi-
fied. Adipose tissue[24], CD4+ T cells or macrophages[25,26] have all been proposed to
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contribute. Increases in serum cytokines (particularly IL6 and TNF) are generally thought to be
a pathological consequence of aging, as they correlate with risk of classical “diseases of age”
such as dementia[27], stroke[28], cardiovascular disease[29] as well as frailty[30,31] and all-
cause mortality[32,33]. Conversely, lower than average levels of age-associated inflammation
predict good health in age[34]. Furthermore, most chronic inflammatory conditions are char-
acterized by increased numbers of CD14++CD16+ and/or CD14++CD16- monocytes
[35,36,37,38,39,40,41]. Herein, we investigate the role of monocytes, which are known to be
critical mediators of chronic inflammation, contribute to age-associated inflammation.
Inflamm-aging contributes to susceptibility to infectious disease, and particularly pneumo-
nia, which is a major cause of death in the elderly[42]. Susceptibility to pneumonia correlates
with increased levels of IL6 and TNF before an infection [43,44,45]. When young mice are
infused with TNF, they become as susceptible to experimental infection with Streptococcus
pneumoniae as old mice[46]. Using a mouse model of pneumococcal colonization, we investi-
gated whether changes in monocyte phenotype adversely affect host defense towards S. pneu-
moniae. We show that with age that there is an in increase in circulating Ly6C+ monocytes
during the steady state due to increased expression of CCR2. Using heterochronic bone mar-
row chimeras, we demonstrate that the aging microenvironment, rather than intrinsic changes
in myeloid progenitors, drives changes in monocyte phenotype, including decreased expression
of F4/80 (a marker of maturity), and increased expression of CCR2 (required for monocyte
mobilization). We demonstrate that age-associated increases in TNF are the driving factor
behind changes in monocyte phenotype, as TNF deficiency or treatment with anti-TNF anti-
bodies normalizes expression of CCR2 on Ly6C+ monocytes. Decreased CCR2 expression
results in decreased numbers of monocytes in the circulation and reduced production of TNF
and IL6. Finally, we demonstrate that, although TNF levels and the recruitment of Ly6C+
monocytes are increased in old mice during nasopharyngeal S. pneumoniae colonization, this,
counterintuitively, results in diminished bacterial clearance.
To our knowledge, this is the first mechanistic study that investigates the role of Ly6C+
monocytes as central mediators of inflamm-aging and demonstrates that TNF is a key contrib-
utor to age-associated defects in myeloid phenotype and anti-bacterial function. These data
indicate that Ly6C+monocyte frequency and increased production of pro-inflammatory cyto-
kines contributes to both age-associated inflammation and declining anti-bacterial immunity.
Results
Ly6C+ monocytes increase with age in the blood and bone marrow but
are phenotypically and functionally different
It has been reported that with age the proportion of myeloid cells and cytokines in the blood is
increased. We quantitated circulating leukocyte populations in old (18–22 mo) mice and found
that, consistent with previously published data[47,48], there was a decrease in the percentage
of T cells and an increase in the number of myeloid cells when compared with young (10–14
wk) mice (Fig 1A & S1A Fig). Analysis of monocyte subsets indicated that the absolute number
of both Ly6Chigh and Ly6Clow monocytes was increased with age (Fig 1A). An increase in
Ly6Chigh monocyte frequency within the blood of old mice was paralleled by a similar increase
in the bone marrow (Fig 1B), suggesting that increased myelopoiesis within the bone marrow
may precede increased numbers of these cells in the blood. Consistent with this, we also found
that the number of M-CSF responsive cells (myeloid precursors and monocytes capable of dif-
ferentiating into bona fide macrophages ex vivo) in the bone marrow was significantly
increased with age (S1C Fig).
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Fig 1. Ly6Chigh monocytes are increased with age, expressmore CCR2 and less F4/80. (A) Total numbers of Ly6Chigh and Ly6Clow monocytes were
quantitated in the blood of old (18–22 mo) WT C57Bl6/J mice and compared to that from young (10–14 wk) mice. The data represent the mean (± SEM) of 6
mice. (B) Analysis of the Ly6Chigh monocytes as a percentage of CD45+ cells in the blood and bone marrow of young and old mice (± SEM; n = 6). (C) CCR2
expression on Ly6Chigh monocytes in the bone marrow and blood of old mice is higher than young controls as determined by flow cytometry (n = 6–8). (D)
The mean expression of the macrophage maturity marker, F4/80, on Ly6Chigh monocytes in the bone marrow and blood of young and old mice (n = 6–8). (E)
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The C-C chemokine receptor type 2 (CCR2) is expressed at high levels on Ly6Chigh mono-
cytes and is essential for their entry into the blood in response to the production of CCL2[49].
Since CCR2 is required for monocytes, and especially Ly6Chigh monocytes, to leave the bone
marrow and enter the blood, we hypothesized that enhanced CCR2 expression on Ly6Chigh
monocytes could prompt their premature emigration from the bone marrow and could explain
the increased number of Ly6Chighmonocytes seen with age. CCR2 expression was measured on
Ly6Chigh monocytes in the blood and bone marrow of old mice and found to be dramatically
increased (Fig 1C). Consistent with previous research[1], CCR2 expression was more pro-
nounced on Ly6Chigh monocytes (S1E Fig). As Ly6Chigh monocytes represent an intermediate
stage in monocyte-to-macrophage differentiation, we investigated their maturity using the
monocyte/macrophage maturity marker, F4/80. Interestingly, we found that there was an inverse
relationship between CCR2 expression and F4/80 expression on Ly6Chigh monocytes in the
blood of old mice. With age, these cells showed significantly decreased levels of F4/80 (Fig 1D),
suggesting that their increased CCR2 expression may prompt these cells to enter the circulation
in an immature state. When CCR2 expression was measured on myeloid precursors undergoing
M-CSF-stimulated differentiation into macrophages, increased CCR2 expression occurred dur-
ing an intermediate stage of differentiation (day 5) on cells from old mice (S1D Fig).
To determine whether increased CCR2 expression was sufficient to increase Ly6Chigh
monocyte egress, we intraperitoneally injected young and old mice with 100 nM of CCL2 and
measured Ly6Chigh monocyte recruitment after 4 hours. We found that despite administering
an equivalent dose of CCL2, Ly6Chigh monocyte recruitment to the peritoneum was increased
~5-fold in old mice relative to young mice (Fig 1E). A less dramatic increase in Ly6Clow mono-
cytes was also observed (Fig 1E), consistent with previous studies.
Monocytes are potent producers of pro-inflammatory cytokines with age
Since we found that there was an expansion of monocytes with age and these cells are known
to be potent producers of pro-inflammatory cytokines, we postulated that they might contrib-
ute significantly to age-associated inflammation. To determine whether the increased numbers
of monocytes with age contributed to age-associated increases in IL6 production, we targeted
this cell population using carboxylated polystyrene microparticles (PS-MPs), which have been
shown by others to lead to a reduction of primarily Ly6Chigh monocytes in the blood[50]. We
found that when circulating monocytes were decreased in old mice (Fig 2A), this reduced cir-
culating levels of IL6 (Fig 2B). In humans, CD14++CD16+HLA-DR+/intermediate monocytes
are the biggest producers of inflammatory cytokines under a variety of stimulation conditions
[3]. Intracellular cytokine staining reveals that of the three human monocyte populations (clas-
sical, intermediate, non-classical) intermediate monocytes are the major producers of TNF (Fig
3A) and IL6 (Fig 3B) after stimulation with LPS or S. pneumoniae and older donors (63–70
yrs) produce more cytokines than younger donors (26–52 yrs). Additionally, CD14+ mono-
cytes isolated from PBMCs from older donors produced more TNF (Fig 3C) and IL6(Fig 3D)
in response to LPS than did younger donors. As in mice, the numbers of intermediate mono-
cytes may be influenced by levels of age-associated inflammation since the frequency of inter-
mediate monocytes, are positively correlated with plasma TNF (Fig 3E) as has been shown to
occur in other chronic inflammatory conditions [51]. A weaker correlation (p<0.02) was
Cells recruited to the peritoneum were quantitated 4 hours after administration of 100 nM CCL2. The recruitment of Ly6Chigh and Ly6Clow monocytes was
greater in old mice (± SEM; n = 5). Statistical significance was determined by two-tailed Mann-Whitney-Wilcoxon test or two-way ANOVA with Fisher's LSD
post-test where appropriate. * indicates p < .05, ** indicates p < 0.005, *** indicates p < 0.0005 and **** indicates p < 0.00005. (A-D) is representative of 4
independent experiments; (E) is representative of 2 independent experiments.
doi:10.1371/journal.ppat.1005368.g001
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observed between TNF levels and the numerically dominant classical monocytes and no corre-
lation was found between non-classical monocytes and TNF (p = 0.2).
The age-associated increase in circulating pro-inflammatory monocytes
is regulated by TNF
To determine whether age-related changes in Ly6Chigh monocyte numbers, phenotype and
inflammatory capacity were caused by changes in the aging bone marrow microenvironment or
due to intrinsic changes in the myeloid precursors themselves, we created heterochronic bone
marrow chimeras. When young bone marrow was transferred to old recipient mice the number
of Ly6Chigh and Ly6Clow monocytes was increased to levels comparable to old mice (Fig 1A) or
old recipient mice who had received old donor marrow (Fig 4A). In contrast, young recipient
mice that had received old donor marrow had Ly6Chigh and Ly6Clow monocyte numbers compa-
rable to young mice (Fig 1A) or to young recipient mice that had received young donor bone
marrow (Fig 4A). In addition, the increase in CCR2 expression observed on circulating mono-
cytes from old mice (Fig 1C) was also observed in circulating monocytes from old recipient mice
who had received young donor marrow but not on young recipient mice who received old donor
marrow(Fig 4B). These data demonstrate that increases of Ly6C+ monocytes and increased
CCR2 expression occur in a manner entirely dependent on the bone marrow microenvironment.
Since TNF is one of the central cytokines associated with inflamm-aging, we investigated
whether TNF was sufficient to drive expansion of the Ly6Chigh monocytes. We aged TNF
knockout (KO) mice (18–22 mo) and quantified Ly6Chigh monocytes in their blood. We found
that, unlike their WT counterparts, old TNF KOmice did not have higher numbers of circulat-
ing Ly6Chigh monocytes (Fig 4C), but did have an increase in bone-marrow Ly6Chigh mono-
cytes compared to their young counterparts (Fig 4D). Surface expression of CCR2 on Ly6Chigh
monocytes in both the blood (Fig 4E) and the bone marrow (Fig 4F) of old TNF KOmice was
comparable to the levels seen in young mice. Similarly there were no changes in Ly6Clow
monocytes in aged TNF KOmice (S1D Fig).
Fig 2. Ly6Chigh monocytes contribute to elevated levels of serum IL6 and TNF in agedmice. Young and old mice were injected with 500 nm negatively-
charged polystyrene microparticles (PS-MPs) previously shown to reduce numbers of circulating Ly6Chigh monocytes. Circulating monocyte populations (A)
and IL6 levels in whole blood (B) were quantitated after 24 hours. Statistical significance was determined by two-tailed Mann-Whitney-Wilcoxon test. *
indicates p < .05, ** indicates p < 0.005, *** indicates p < 0.0005 and **** indicates p < 0.00005. (A-B) is representative of ± SEM of 5 mice from 2
independent experiments.
doi:10.1371/journal.ppat.1005368.g002
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These data suggest that increased production of Ly6Chigh monocytes in the bone marrow
occur independent of TNF, but that increases in CCR2 expression on these cells in the bone
marrow, and their subsequent mobilization to the blood is TNF-dependent. Consistent with
our observation that Ly6C+monocytes contribute to elevated levels of circulating cytokines
Fig 3. Human CD14++CD16+HLA-DR+ (intermediate) monocytes produce more inflammatory cytokines with age. Intracellular production of TNF (A)
and IL-6 (B) in classical (CD14++), intermediate (CD14++CD16+) and non-classical (CD14+CD16+) monocytes from young and elderly donors in response to
LPS (50 ng/ml) and S. pneumoniae (5 x106 CFU). C) The secretion of TNF and D) IL-6 for isolated CD14+monocytes in response to LPS for young and older
donors. E) The frequency of intermediate monocytes were found to have a significant, positive correlation with the levels of serum TNF (β = 2.78, p<0.006).
(A-D) is representative of ± SEM of n = 7 young donors (26–52 yrs) and n = 6 older donors (63–70 yrs) *indicates p<0.05, and ** indicates p< 0.05.
Intermediate monocyte (CD14++CD16+HLA-DR+) count (cells per microlitre of whole blood) increases relative to serum levels of TNF in older donors
(n = 94, 61-100yrs).
doi:10.1371/journal.ppat.1005368.g003
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Fig 4. TNF drives increases in circulating Ly6Chigh monocytes. (A) Total numbers of Ly6Chigh and
Ly6Clow monocytes in the blood of heterochronic bone marrow chimeric mice. Old recipient mice which
receive young donor marrow have increased numbers of circulating Ly6Chigh and Ly6Clow monocytes which
are comparable to old recipient mice that receive old donor marrow. Young recipient mice that receive old
donor marrow do not have an increase in Ly6Chigh and Ly6Clow monocytes. The data represent the mean (±
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with age (Fig 2), old WT mice produced more IL6 than young mice following 24 hour stimula-
tion of whole blood with either PBS or LPS (Fig 4G). In comparison, old TNF KOmice, which
did not have an increase of Ly6C+monocytes in the blood did not have an age-associated
increase in IL6 in whole blood in response to PBS or LPS (Fig 4G).
Blockade of TNF reverses age-associated increases in Ly6Chigh
monocytes and inflammation
We investigated whether it was chronic or acute exposure to TNF that mediated age-related
increases in serum IL6 and changes in monocyte phenotype and function. We first sought to
determine whether increases in circulating Ly6C+ monocytes were inducible after administra-
tion of TNF. TNF (5ng/g) was administered intraperitoneally for 3 weeks, a time point chosen
because it would allow for multiple cycles of monopoiesis and complete turnover of pre-formed
monocytes [52]. Young mice showed a large increase in Ly6Chigh monocytes in the blood and a
less dramatic increase of Ly6Clow monocytes (Fig 5A). This was accompanied by a significant
increase in serum IL6 in TNF-treated, but not vehicle control mice (Fig 5B). We next asked
whether blocking TNF could reduce numbers of Ly6C+ monocytes in old animals. Young and
old WTmice were administered Adalimumab (HUMIRA), a human monoclonal antibody spe-
cific for TNF, or an IgG isotype control at a dose of 50 ng/g for a period of three weeks via
intraperitoneal injection. Anti-TNF therapy reduced the levels of plasma TNF from an average
of 1.5 pg/ml to below the level of detection (LOD = 0.25pg/ml) in old mice and decreased the
number of circulating Ly6Chigh but not Ly6Clow monocytes in the blood to levels similar to
young mice (Fig 5C). Anti-TNF therapy also reduced CCR2 expression on Ly6Chigh monocytes
in the blood of old mice to levels that are equivalent to those seen in young mice (Fig 5D) and
reduced the percentage of monocytes that stained positive for IL6 or TNF by ICS after LPS
stimulation (Fig 5E). Anti-TNF treatment reduces IL6 levels in the circulation of old mice (Fig
5F) and when blood from young and old mice treated with anti-TNF or IgG controls was stim-
ulated with LPS, IL6 levels were lower in old mice treated with anti-TNF compared to those
that were treated with IgG(Fig 5G).
Circulating and recruited Ly6Chigh monocytes are increased with age
during S. pneumoniae colonization
In order to determine if age-related changes in Ly6Chigh monocyte numbers or maturity might
play a role in defective anti-bacterial immunity with age, we investigated the trafficking of
these cells following nasopharyngeal colonization of young and old mice with the bacterial
pathogen, S. pneumoniae. We selected this pathogen specifically because of the high burden of
disease caused by S. pneumoniae in elderly individuals and because it has been previously dem-
onstrated that its clearance from the nasopharynx is largely dependent on recruited mono-
cytes/macrophages[53,54]. Following intranasal delivery of S. pneumoniae, we found that old
SEM) of 5 mice. (B) CCR2 expression on circulating monocytes is elevated when the recipient mouse is old,
indicating that the bone marrow microenvironment drives changes in CCR2 expression (CCR2 MFI± SEM;
n = 5). (C-D) The percent Ly6Chigh monocytes as a proportion of CD45+ cells in the (C) blood or (D) bone
marrow of young and old WT and TNF KOmice was quantitated (± SEM; n = 4–6). (E-F) Expression of CCR2
on Ly6Chigh monocytes in the (E) blood or (F) bone marrow of young and old WT and TNF KOmice (n = 4–8)
demonstrate that the presence of TNF drives CCR2 expression with age. (G) IL6 production in whole blood
from young and old TNF KOmice stimulated with 100 ng/ml of LPS or a vehicle control for 24 hours was
quantitated by ELISA (± SEM; n = 5). Statistical significance was determined by two-tailed Mann-Whitney-
Wilcoxon test, one-way or two-way ANOVA with Fisher's LSD post-test where appropriate. * indicates p <
.05, ** indicates p < 0.005, *** indicates p < 0.0005 and **** indicates p < 0.00005. (A-B) is representative
of 2 independent experiments; (C-G) is representative of 3 independent experiments.
doi:10.1371/journal.ppat.1005368.g004
Age-Associated Inflammation Impairs Anti-bacterial Immunity
PLOS Pathogens | DOI:10.1371/journal.ppat.1005368 January 14, 2016 9 / 23
Fig 5. Anti-TNF therapy can reverse the age-associated increase in circulating Ly6Chigh monocytes.
(A-B) Young mice were give 200 ng/ml of TNF intraperitoneally every other day for 3 weeks. Numbers of
circulating Ly6Chigh and Ly6Clow monocytes (A) and serum IL6 (B) were quantitated. The data represent the
mean (± SEM) of 5 mice. (C) Young and old WTmice were treated for 3 weeks with a neutralizing TNF
antibody or IgG control and total numbers of circulating Ly6Chigh monocytes were quantitated by flow
Age-Associated Inflammation Impairs Anti-bacterial Immunity
PLOS Pathogens | DOI:10.1371/journal.ppat.1005368 January 14, 2016 10 / 23
mice had defects in clearance of the colonization. By Day 21 most of the young mice had
cleared the bacteria, while old mice still harbored high bacterial loads (Fig 6A). Old mice were
also more susceptible to bacterial invasion to the lungs at day 3 (Fig 6B) and mortality through-
out the course of colonization (Fig 6C). Although serum production of CCL2 in old mice was
comparable to that of young mice (Fig 6D), old mice had increased Ly6Chigh but not Ly6Clow
monocyte numbers in the circulation during colonization (days 3, 7, 14, 21) (Fig 6E).
We next investigated whether the monocytes/macrophages recruited in the context of age
had maturity defects (as measured by F4/80 expression). In old mice, circulating Ly6Chigh
monocytes had decreased expression of F4/80 during colonization (Fig 6F), suggesting that the
decreased F4/80 expression seen in the bone marrow during the steady state (Fig 1D) perpetu-
ates following their egress during infectious challenge. Despite their inability to control bacterial
loads in the nasopharynx, old mice also had a significant increase in the expression of CCL2 in
the nasopharynx during colonization (Fig 6G), and had higher numbers of recruited Ly6Chigh
monocytes (Fig 6H) and macrophages (Fig 6I) to the nasopharynx compared to young mice.
Although resident macrophages from young and old mice present in the nasopharynx during
the steady state expressed equal levels of F4/80, monocytes/macrophages recruited to the naso-
pharynx during S. pneumoniae colonization showed decreased expression F4/80(Fig 6J), similar
to that seen in their counterparts in the blood(Fig 6F). In order to determine whether bacterial
binding and internalization was different between monocytes derived from young and old mice
we compared bacterial binding (measured at 4°C) and internalization/killing (measured at
37°C). Although there was a significant decrease in bacterial binding between young and old
mice, this did not appear to affect internalization or bacterial killing (Fig 6K).
Ly6C+ monocytes impair clearance of S. pneumoniae with age
Although trafficking of blood monocytes was not impaired with age, old mice nonetheless dis-
played impaired clearance of S. pneumoniae. To explain this, we hypothesized that high levels
of recruited but developmentally immature Ly6Chigh monocytes could, in fact, have negative
consequences for clearance. Interestingly, TNF, which we showed caused increased numbers of
Ly6Chigh monocytes in the blood (Fig 4A), was increased with age during S. pneumoniae colo-
nization in the nasopharynx (Fig 7A) and blood (Fig 7B). We next compared nasopharyngeal
bacterial loads in WT and TNF KOmice, to determine whether TNF production affected bac-
terial clearance. Although TNF had no effect on clearance of colonization in young mice we
found that old TNF KOs had significantly fewer CFUs in the nasopharnyx compared to their
old WT counterparts at day 3 (Fig 7C). Old TNF KOmice also had decreased recruitment of
Ly6Chigh monocytes in the blood (Fig 7D), confirming that TNF can regulate mobilization of
these cells during infection as well as in the steady state.
To determine whether the decreased recruitment of Ly6Chigh monocytes we observed was
responsible for improved bacterial clearance in old TNF KOmice, we preferentially targeted
cytometry. The data represent the mean (± SEM) of 4 mice. (D) The mean CCR2 expression on circulating
Ly6Chigh monocytes in young and old mice treated with either anti-TNF or IgG was quantitated and found to
be reduced with anti-TNF treatment (n = 4). (E) Intracellular staining of IL6 and TNF on blood monocytes after
a 4 hour stimulation with LPS from young and old WTmice treated with either anti-TNF or IgG demonstrates
that the number of monocytes that stain positive for IL6 or TNF are decreased with anti-TNF therapy(± SEM;
n = of 4). (F) Serum IL6 is reduced in old mice treated with anti-TNF but not the IgG control. (G) IL6 production
in whole blood following stimulation with LPS or a vehicle control after 24 hours from young and old WTmice
given either anti-TNF or IgG (± SEM; n = 4). Statistical significance was determined by two-tailed Mann-
Whitney-Wilcoxon test, one-way or two-way ANOVA with Fisher's LSD post-test where appropriate. *
indicates p < .05, ** indicates p < 0.005, *** indicates p < 0.0005 and **** indicates p < 0.00005. (A-G) are
representative of 1 experiment with n = 4 mice.
doi:10.1371/journal.ppat.1005368.g005
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Fig 6. Old mice have increased numbers of circulating and recruited Ly6Chigh monocytes during the
course of S. pneumoniae colonization. (A) Colony forming units (CFUs) in nasal lavages from young and
old WTmice were quantified on days 3, 7, 14 and 21 following intranasal colonization with S. pneumoniae (±
SEM; n = 5–22). (B) CFUs of S. pneumoniae in the lungs at day 3 following intranasal colonization (± SEM;
n = 9–22). (C) Survival of young and old mice after intranasal S. pneumoniae colonization (± SEM; n = 12).
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(D) Total serum CCL2 in young and old mice following intranasal S. pneumoniae colonization was measured
by a high sensitivity ELISA. The data represent the mean (± SEM) of 3 mice per time point. (E) Ly6Chigh
monocytes as a percent of CD45+ cells in the blood of young and old WTmice during nasopharyngeal S.
pneumoniae colonization (± SEM; n = 5–8) was measured by flow cytometry. (F) Mean expression of F4/80
on Ly6Chigh monocytes in the blood of old mice during S. pneumoniae colonization is decreased as compared
to young mice. (G) Levels of CCL2 transcript in the nasopharynx during the course of S. pneumoniae
colonization were measured by quantitative PCR. (± SEM; n = 3). (H-I) Total numbers of (H) Ly6Chigh
monocytes and (I) macrophages detected by flow cytometry in the nasopharnyx of young and old mice during
S. pneumoniae colonization (± SEM; n = 3–8). (J) Mean F4/80 expression on nasopharyngeal macrophages
is lower in old mice during S. pneumoniae colonization (± SEM; n = 3–8). Statistical significance was
determined by two-tailed Mann-Whitney-Wilcoxon test, one-way or two-way ANOVA with Fisher's LSD post-
test. (K) Circulating blood monocytes from old mice bind fewer TRITC-labelled S. pneumoniae (4°C) but there
is no difference in internalization of the bacteria (37°C). Survival in (C) was determined by the Mantel-Cox
Log-rank test. * indicates p < .05, ** indicates p < 0.005, *** indicates p < 0.0005 and **** indicates
p < 0.00005. (A-J) is representative of 3 independent experiments.
doi:10.1371/journal.ppat.1005368.g006
Fig 7. Reducing TNF-regulated recruitment of Ly6Chigh monocytes during S. pneumoniae colonization in old mice reduced nasopharyngeal
bacterial loads. (A-B) TNF in the (A) nasopharnyx and (B) serum of young and old mice during S. pneumoniae colonization as measured by qPCR and
ELISA, respectively (± SEM; n = 3–5). (C) CFUs in nasal lavages of old WT and old TNFmice on day 4 after colonization with S. pneumoniae (± SEM;
n = 6–8, one independent experiment of two shown). (D) Ly6Chigh monocytes as a percent of circulating CD45+ cells in old WT and TNF KOmice on day 4 of
S. pneumoniae colonization (± SEM; n = 3–4, one independent experiment of two shown). Statistical significance was determined by two-tailed Mann-
Whitney-Wilcoxon test, one-way ANOVA or two-way ANOVA with Fisher's LSD post-test where appropriate. * indicates p < .05, ** indicates p < 0.005, ***
indicates p < 0.0005 and **** indicates p < 0.00005.
doi:10.1371/journal.ppat.1005368.g007
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this cell population using negatively-charged polystyrene microparticles (PS-MPs) (Fig 8A).
We observed that there were also decreases in monocytes in the lungs, but not neutrophils with
this treatment (S2 Fig). Old mice were given PS-MPs on day prior to and every 3 days during
the course of S. pneumoniae colonization and bacterial loads were measured at day 7. PS-MP-
treated old mice had increased survival (Fig 8B), less weight loss (Fig 8C)and lower bacterial
loads in the nasopharynx (Fig 8D), lungs (Fig 8E) and spleen (Fig 8F) compared to old control
mice. Similar results were observed with Gr-1 antibody, which reduces numbers of monocytes
and neutrophils. These data confirm that increased trafficking of this cell type during S. pneu-
moniae colonization impairs host defense.
Discussion
Epidemiological data strongly suggests that there is a reciprocal link between pneumonia and
age-associated inflammation. Older adults who have higher than age-average levels of the cyto-
kines TNF and IL6 in their circulation have a much higher risk of acquiring pneumonia than
their peers who have lower than age-average levels[55]. Although a robust inflammatory
response is generally thought to be protective against infection, in the elderly, high levels of cir-
culating inflammatory cytokines during pneumonia are associated with more severe disease
and higher mortality[56,57]. Similarly, having a chronic inflammatory disease such as demen-
tia, diabetes, or cardiovascular disease is strongly associated with susceptibility to acquiring
pneumonia [58,59,60]. Conversely, having a pneumonia in mid- to late-life can often exacer-
bate or accelerate sub-clinical or existing chronic inflammatory conditions and can be the har-
binger of declining health and decreased quality of life[58,59]. Although descriptions of this
reciprocal relationship between chronic, age-associated inflammation and pneumonia, espe-
cially that caused by S. pneumoniae, are strong, the mechanistic explanations are weak. Herein
we demonstrate that monocytes, both contribute to age-associated inflammation and are
impaired by chronic exposure to the inflammatory cytokine TNF, and this ultimately impairs
their anti-pneumococcal function.
Our data using aged TNF KOmice or anti-TNF therapy indicate that the increased levels of
TNF that occur with age impair monocyte development and ultimately anti-bacterial immu-
nity. Although macrophages have previously been shown to promote inflamm-aging[61], our
data suggest that this may begin earlier in myelopoesis since monocytes produce more inflam-
matory cytokines such as TNF and IL6 with age and ablation of monocytes reduces levels of
serum cytokines. The increase in circulating monocytes did not occur in old TNF KO mice.
Furthermore, by treating youngWTmice with a low-dose regime of TNF delivered intraperito-
neally, we found that Ly6C+ monocytes were increased in the blood in a manner similar to old
mice, demonstrating that TNF is sufficient to increase numbers of circulating Ly6C+ mono-
cytes. Monocytes appear to be both highly responsive to increased levels of TNF but also seem
to be a major source of age-associated TNF.
Our observational studies in humans imply that the numbers of intermediate (CD14+-
+CD16-) monocytes, which we have previously shown express higher levels of CCR2 with age
[62], correlate with increased levels of TNF and contribute to hyper-inflammatory responses to
bacterial infection. Studies in patients on anti-TNF therapy for rheumatoid arthritis validate
our observations that TNF drives increases in inflammatory monocytes. In these patients anti-
TNF therapy decreases the levels of circulating CD14++CD16- monocytes in the blood and
synovial fluid as well as decreases CCR2 expression on peripheral blood mononuclear cells and
thus is consistent with our data demonstrating that TNF-mediated changes in CCR2 expres-
sion are sufficient to alter the numbers of Ly6Chigh monocytes in the circulation [63,64]. Inter-
estingly, decreases in CD14++CD16- monocytes correlate with a positive prognostic response
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Fig 8. Depletion of inflammatory monocytes improves outcome to S. pneumoniae infection in old mice.Mice (n = 7-10/group) were injected with
PS-MP day -1, 0, +1, +3 and +5 during colonizationwith S. pneumoniae. A) The percentage of Ly6Chigh monocytes was significantly reduced in old mice
treated with PS-MP (see S3 Fig). B) Survival was significantly improved in old mice treated with PS-MP (p = 0.005, Mantel-Cox log-rank test). C) Both young
and old mice treated with PS-MP lost less weight than their control counterparts (*,p<0.05, one-way ANOVA with uncorrected Fisher's LSD). Levels of S.
pneumoniae in the D) nasal wash, E) lungs and F) spleen were lower in old mice treated with PS-MP. Fewer young mice had bacteria in their lungs and
spleens when they were treated with PS-MP. (*,p<0.05, **,p<0.005 one-way ANOVA with uncorrected Fisher's LSD). CFU count for mice that reached
endpoint before day 7 are not included.
doi:10.1371/journal.ppat.1005368.g008
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for patients, but whether this is because they contribute directly to disease progression or the
inflammatory tone of rheumatoid arthritis is not known [63].
Increases in Ly6Chigh monocytes are associated with defects in maturity. Interestingly, our chi-
mera data demonstrate that phenotypic changes in monocytes (i.e. CCR2 and F4/80 expression)
were not due to intrinsic defects in myeloid precursors but rather the influence of the bone mar-
rowmicroenvironment, and, since these changes did not occur in TNF KOmice, TNF produced
in the context of the microenvironment. Although F4/80 levels were equivalent on blood mono-
cytes during the steady state, they were lower on Ly6Chigh monocytes/differentiating macro-
phages recruited during nasopharyngeal S. pneumoniae colonization in old mice. These changes
had functional significance; despite robust Ly6Chigh monocyte recruitment and TNF production
in old mice, bacterial clearance was significantly impaired. In fact, our data suggest that TNF is
detrimental to clearance of S. pneumoniae from the nasopharynx with age, as old TNF KOmice
had lower bacterial loads compared to their WT counterparts. Although TNF is often thought of
as a key anti-bacterial cytokine, mouse studies have demonstrated that TNF is required for con-
trol for S. pneumoniae bacteremia but not for survival in lung infection[65]. In our study, old
TNF KOmice recruited fewer circulating Ly6Chigh monocytes during S. pneumoniae colonization
compared to oldWTmice and counter-intuitively, this appeared to be protective against infec-
tion as when we depleted circulating Ly6Chigh monocytes using carboxylated polystyrene micro-
particles colonization, bacterial loads in the nasopharynx decreased. These data are consistent
with the clinical observation that rheumatoid arthritis patients (who have high levels of circulat-
ing TNF) are at increased risk of pneumonia but that there is no increase in risk of pneumonia
for patients on anti-TNF therapy [66]. Whether pneumonia risk is decreased with anti-TNF ther-
apy is not known; however, patients on anti-TNF therapy do live slightly longer than their
untreated counterparts, despite an increased risk in re-activation of chronic infections[67,68].
These observations have important therapeutic significance, since the belief that host
responses to bacteria are impaired with age due to poor innate cell recruitment has been the
foundation of two large clinical trials testing the use of cytokines (G-CSF) to mobilize myeloid
cells as an adjunct to antibiotics and one clinical trial testing GM-CSF as an adjuvant for pneu-
mococcal vaccination. Although mouse models (tested in young mice) showed promise, these
strategies all failed when tested in populations where the median ages were 59, 61 and 68,
respectively [reviewed in[69] and[70]]. Our data suggests that use of G-CSF, GM-CSF or other
myeloid chemoattractant-based therapies in older adults would enhance recruitment of a pop-
ulation that is fundamentally immature and predisposed towards TNF and IL6 production that
provides no functional benefit to the host for clearance and may even exacerbate infection.
In summary, our data suggest that monocytes are both contributors to age-associated inflam-
mation and have altered anti-pneumococcal function as a result of age-associated inflammation.
Lowering levels of TNF may be an effective strategy in improving host defence against S. pneu-
moniae in older adults. In fact, it has been shown that immunosuppressive steroid use in combi-
nation with antibiotics reduces pneumonia mortality in the elderly[71,72,73,74], although
uptake for this therapy has been limited. Although it may be counterintuitive to limit inflamma-
tory responses during a bacterial infection, the clinical observations and our animal model indi-
cates that anti-bacterial strategies need to be tailored to the age of the host.
Materials and Methods
Ethics statement
All experiments were performed in accordance with Institutional Animal Utilization protocols
approved by McMaster University’s Animal Research Ethics Board (#13-05-13 and #13-05-14)
as per the recommendations of the Canadian Council for Animal Care.
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Participants or Power of Attorney for participants were approached to determine interest in
the study. Informed written consent was obtained from the participant or their legally autho-
rized representative approved by the Hamilton Integrated Research Ethics Board (#09–450).
Animals
Female C57BL/6J mice were purchased from Jackson Laboratories and aged in house. Coloni-
zation was performed as previously described[75]. To protect from age-related obesity aging
mice are fed with a low protein diet Teklad Irradiated Global 14% protein Maintenance Diet
and provided with an exercise wheel, as were young controls. The average weight of a young
mouse is this study is 20g+/-1g and the old mice are on average, 27g+/-2.5g. TNF knockout
mice (KO) mice (C57BL/6J background) were bred in the barrier unit at the McMaster Univer-
sity Central Animal Facility (Hamilton, ON, Canada) as previously described[76]. All mice
were housed in specific pathogen-free conditions. Continual monitoring of the health status of
mice was performed.
Human monocytes
Monocyte frequency was measured in whole blood according to staining procedures described
in [62]. Briefly, intermediate monocytes were positive for the expression of HLA-DR and
CD16, stained brightly for CD14, and were negative for lymphoid and neutrophil markers
(CD2, CD3, CD15, CD19, CD56, and NKp46). They are presented as cells per microlitre of
whole blood, which was measured using CountBright Absolute Counting Beads (Life Technol-
ogies, CA, USA). Serum TNF was measured in elderly donors (61–100 yrs) using the Milliplex
High Sensitivity ELISA kit (Millipore, ON, CA).
For intracellular cytokine staining, described in [62], the production of TNF and IL-6 was
measured in classical (CD14++), intermediate (CD14++CD16+) and non-classical (CD14
+CD16+) monocytes after a 6 hour incubation period in the presence of 50 ng/ml LPS and 5 x
106 CFU of heat-killed S. pneumoniae. For cytokine secretion, CD14+ monocytes were isolated
from PBMCs of young(26–52 yrs) and older (63–70 yrs)by positive selection procedure (Stem-
cell, BC, CAN) and stimulated for 22 hours in the presence of 50 ng/ml LPS. TNF and IL-6
were measured by ELISA (eBioscience, CA, USA).
Flow cytometry
Monoclonal antibodies with the following specificities were used in this study: F4/80 (APC),
Ly6C (FITC), CD45 (eFluor 450), CD11b (PE-Cy7 or PerCPCy5.5), MHC II (PerCP eFluor
710), CD3 (Alexa Fluor 700), CD4 (Alexa Fluor 605NC), Ly6G (PE), Ter119 (PE), B220 (PE),
NK1.1 (PE), CCR2 (PE), IL6 (PE) or TNF (PECy7). Blood and single cell suspensions of lung
were stained according to previously published procedures [75]. Total cell counts were deter-
mined using CountBright Absolute Counting Beads (Life Technologies). To attain a single-cell
suspension of mouse lung tissue, half a lung was collected from each S. pneumoniae-colonized
mouse and kept on ice. Immediately following, each lung was mechanically dissociated and
enzymatically degraded using a Miltenyi Biotec Lung Dissociation Kit (Cat#: 130-095-927)
along with the gentleMACS Octo-Dissociator with Heaters (Cat#: 130-096-427). Following dis-
sociation as per protocol, cell suspensions were filtered (70 μM cell filter) and centrifuged at
300 x g for 10 min. Subsequently, single-cell suspensions were re-suspended in phosphate-buff-
ered saline & processed for flow cytometry. A gating strategy for distinguishing Ly6Chigh and
Ly6Clow monocytes is presented in S3 Fig.
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Cytokine administration
100 nM of recombinant murine CCL2 (endotoxin-free, eBioscience) was diluted in sterile
saline and administered intraperitoneally. Recruited cells were isolated via peritoneal lavage
and quantitated using flow cytometry. Murine recombinant TNF (eBioscience) diluted in ster-
ile saline was administered intraperitoneally every other day for 3 weeks at a dose of 5 ng per
gram of body weight. Adalimumab (HUMIRA, Abbott Laboratories), a humanized anti-TNF
antibody, or the human IgG isotype control diluted in sterile saline were administered intraper-
itoneally at a dose of 50 ng per gram of body weight for a period of 3 weeks.
Ly6Chigh monocyte depletion
FITC Fluoresbrite 500 nm carboxylated polsytrene microparticles (PS-MPs) were obtained
from Polysciences. PS-MPs were injected via tail vein at 4 x 109 particles in 200 μl as previously
described[50]. Monocyte depletion was confirmed by flow cytometry.
Measurement of cytokine production
Serum TNF and CCL2 was measured using high-sensitivity ELISA as per manufacturer's
instructions (Meso Scale Discovery). For quantitative PCR analysis, RNA Lysis Buffer (Qiagen)
was used to collect nasopharyngeal RNA via nasal lavage. RNA was extracted using an RNAqu-
eous Micro Kit (Ambion), reverse-transcribed to cDNA using M-MULV reverse transcriptase
(New England Biolabs) and qPCR was performed using GoTaq qPCR Master Mix (Promega,
WI, USA) and the ABI 7900HT Fast Real-time PCR System (Applied Biosystems, CA, USA) all
to manufacturer’s instructions. Cycle threshold (Ct) values relative to the internal reference
dye were transformed by standard curve, followed by normalization to the housekeeping gene
GAPDH. Normalized results are presented as relative to an internal calibrator sample.
Quantitation of monocyte-bound S. pneumoniae
100μL samples of peripheral blood, were incubated with TRITC-labeled S. pneumoniae (MOI
20) resuspended in 100μL of complete RPMI at 4°C to allow binding, but not uptake. After 30
min of incubation, cells were stained for flow cytometry. Following RBC lysis (1x 1-step Fix/
Lyse Solution eBioscience; ref: 00-5333-57) for 10min, cells were washed 2x with PBS to
remove excess stain and non-adherent bacteria, and re-suspended in FACS wash (10% fetal
bovine solution in PBS). Flow cytometry was performed and the amount of S. pneumoniae
bound by Ly6Chigh monocytes was quantitated based on the mean fluorescent intensities of
TRITC.
Administration of anti-TNF in vivo
Adalimumab (HUMIRA, Abbott Laboratories), a humanized anti-TNF antibody, or the
human IgG isotype control diluted in sterile saline were administered to mice. A dose of 50 ng
per gram of body weight was given intraperitoneally in a volume of 200 μl every other day, for
a period of 3 weeks to young and old WTmice.
Statistics
Unless otherwise mentioned in the figure legend, statistical significance was determined by
two-tailed Mann-Whitney-Wilcoxon tests, one-way analysis of variance or two-way analysis of
variance with Fischer’s LSD post-tests where appropriate.
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Supporting Information
S1 Fig. Age is characterized by myeloid skewing in mice. (A) Although total leukocyte num-
bers were not altered with age, there was a skewing towards cells of myeloid lineage, with
increases in the total numbers of monocytes and neutrophils, and a decrease in the total num-
ber of T cells in the circulation. (B) The number of bone marrow-derived precursor cells capa-
ble of differentiating into macrophages following M-CSF stimulation was increased in old mice
relative to young mice. (C) With age, bone marrow-derived precursors differentiating into
macrophages ex vivo express heightened CCR2 levels during an intermediate stage of the dif-
ferentiation process. This is in contrast to precursors from young mice, which do not express
peak CCR2 levels until the end of the differentiation process. (D) There were no differences in
Ly6Clow monocyte levels in the circulation in old TNF KOmice. (E) CCR2 levels were signifi-
cantly higher on Ly6Chigh monocytes rather than Ly6Clow monocytes. Statistical significance
was determined by two-tailed Mann-Whitney-Wilcoxon test, one-way ANOVA or two-way
ANOVA with Fisher's LSD post-test where appropriate.  indicates p< .05,  indicates
p< 0.005,  indicates p< 0.0005 and  indicates p< 0.00005.
(TIF)
S2 Fig. Injection with polystryene microparticles (PS-MP) reduces the percentage of
Ly6Chigh monocytes.Mice (n = 7-10/group) were injected with PS-MP day -1, 0, +1, +4and +6
during colonization with S. pneumoniae. Injection of PS-MP reduces in the proportion of
Ly6Chigh monocytes in the (A)circulation and (B) lungs of old mice during S. pneumoniae
colonization. Consequently the proportion of Ly6Clow monocytes in the (C) circulation and
(D) lungs increases, while there is no effect on (E) circulating neutrophils. (F) Reduction of cir-
culating myeloid cells using an anti-Gr-1 antibody also reduces the bacterial load in the nasal
wash of old mice. (,p<0.05, ,p<0.005, , p<0.001 one-way ANOVA with uncorrected
Fisher's LSD). Mice that reached endpoint prior to day 7 were not included in the analysis.
(EPS)
S3 Fig. Flow cytometry gating strategy for Ly6Chigh/low monocytes. To gate on Ly6Chigh
monocytes (circulating & lung-infiltrating), first A) CD45+ cells (leukocytes) are gated upon.
Subsequently, a B) width gate is created to exclude cell aggregates, and C) CD11b+ cells are
selected. Using this population, cells can be divided into D) neutrophils and non-neutrophil
using SSC and Ly6C surface expression. E) Monocytes are gated upon as Ly6C+/SSClow cells,
and those that are F) Ly6Chigh would be defined as Ly6Chigh monocytes. Using a dump gate
positive for NK1.1, CD19, and CD3, it is apparent that no NK cells, B cells or T cells are found
in this population. Isotype controls were used for all experiments.
(TIF)
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